Compare Waran Seri I Pyridam Farma Tbk. (PYFA-W) vs Salim Ivomas Pratama Tbk. (SIMP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Waran Seri I Pyridam Farma Tbk. vs Salim Ivomas Pratama Tbk. — how do they compare? Waran Seri I Pyridam Farma Tbk. trades at Rp62 (market cap 10.7B, 26.5K 24h volume), while Salim Ivomas Pratama Tbk. trades at Rp590 (market cap 9.15T, 3.35M 24h volume). The key difference: Salim Ivomas Pratama Tbk. is far larger — about 855.1× Waran Seri I Pyridam Farma Tbk.'s market cap, and Salim Ivomas Pratama Tbk. is more actively traded (3.35M versus 26.5K). Which is the better fit depends on your goals.
| PYFA-W | SIMP | |
|---|---|---|
Market Cap | 10.7B | 9.15T |
Volume | 26.5K | 3.35M |
Lot | 265 | 33.49K |
Turnover | 1.67M | 1.98B |
Average Price | 62.97 | 592.61 |
Value | 1.67M | 1.98B |
Indicative Equilibrium Price | — | 590 |
Indicative Equilibrium Volume | — | 888 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Waran Seri I Pyridam Farma Tbk.
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA-W →About Salim Ivomas Pratama Tbk.
PT Salim Ivomas Pratama Tbk (the company) was established under its original name of PT Ivomas Pratama base on notarial deed No.65 of Mrs Maria Kidarsa, S.H, dated on 12 Aug, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 46 of Benny Kristianto, S.H., dated Dec 14, 2010, concerning among others, the change in the Company’s name, par value and public offering.
Read more on SIMP →
